Nasdaq Vrtx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq vrtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Vrtx Today - Breaking & Trending Today
StockNews.com upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a buy rating to a strong-buy rating in a report published on Friday morning. Other research analysts have also recently issued research reports about the stock. Wolfe Research began coverage on shares of Vertex Pharmaceuticals in a report on Thursday, February 15th. They issued […] ....
StockNews.com upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a buy rating to a strong-buy rating in a report issued on Friday morning. A number of other equities research analysts also recently issued reports on VRTX. Robert W. Baird downgraded shares of Vertex Pharmaceuticals from a neutral rating to an underperform rating and […] ....
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) posted its quarterly earnings data on Monday. The pharmaceutical company reported $4.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.61 by $1.15, Briefing.com reports. The company had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.58 billion. Vertex […] ....
Sapient Capital LLC purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm purchased 34,486 shares of the pharmaceutical company’s stock, valued at approximately $14,032,000. Other institutional investors also recently modified their holdings of the company. abrdn plc lifted its stake in Vertex Pharmaceuticals by […] ....
Ifrah Financial Services Inc. lowered its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 3.8% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 4,557 shares of the pharmaceutical company’s stock after selling 179 shares during the period. Ifrah Financial Services Inc.’s holdings in […] ....